US Stock MarketDetailed Quotes
BTAI BioXcel Therapeutics
- 2.550
- -0.040-1.54%
Close Apr 18 16:00 ET
- 2.550
- 0.0000.00%
Post 17:30 ET
77.97MMarket Cap-414P/E (TTM)
2.631High2.550Low244.51KVolume2.570Open2.590Pre Close630.14KTurnover1.13%Turnover RatioLossP/E (Static)30.58MShares29.56052wk High-1.38P/B55.31MFloat Cap1.91052wk Low--Dividend TTM21.69MShs Float71.500Historical High--Div YieldTTM3.14%Amplitude1.910Historical Low2.577Avg Price1Lot Size
About BioXcel Therapeutics Company
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Company Profile
SymbolBTAI
Company NameBioXcel Therapeutics
Listing DateMar 8, 2018
Issue Price11.00
Founded2017
CEODr. Vimal Mehta, PhD
MarketNASDAQ
Employees74
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address555 Long Wharf Drive,12th floor
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-475-238-6837
Company Executives
- Name
- Position
- Salary
- Dr. Vimal Mehta, PhD
- Director, Chief Executive Officer and President
- 4.56M
- Matthew T. Wiley
- Senior Vice President and Chief Commercial Officer
- 1.93M
- Javier Rodriguez
- Senior Vice President, Chief Legal Officer and Corporate Secretary
- 1.22M
- Dr. Vincent J. O'Neill, M.D.
- Executive Vice President, Chief of Product Development and Chief Medical Officer
- 90.56K
- Richard I. Steinhart
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Frank D. Yocca, PhD
- Senior Vice President and Chief Scientific Officer
- --
- Dr. Peter Mueller,PhD
- Chairman of the Board and Lead Independent Director
- 295.17K
- Dr. Michal Votruba, M.D.,PhD
- Independent Director
- 242.75K
- Michael Miller
- Independent Director
- 355.25K
- Dr. Sandeep Laumas, M.D.
- Independent Director
- 264.62K
- June Bray
- Independent Director
- 238.70K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg